Aug. 30, 2012 | Allgemein, company news @en, DE, new products
US pharmaceutical company Johnson & Johnson has acquired the licenses to a monoclonal antibody that is to be used, among other things, to combat bone marrow cancer. As part of this movement, the company has acquired a 10% stake in Danish biotechnology firm Genmab....
Aug. 30, 2012 | Allgemein, company news @en, DE, market knowledge
Three health insurance companies are now offering an Internet portal for doctors as part of their supply contracts, for the economic optimisation of outpatient care in the field of parenteral nutrition. The online portal would provide a proposal for the composition...
Aug. 30, 2012 | Allgemein, company news @en, DE, new products
Those insured by private health insurance companies Axa and Gotha can expect a new service: those prescribed drugs from their doctor, or who regularly receive various prescription drugs from multiple physicians can use a drug check to protect themselves, as opposed...
Aug. 30, 2012 | Allgemein, company news @en, DE
ApoBank is currently running an efficiency and savings program, which measures consist of a large-scale IT renewal and changes in personnel policies. Some EUR 40 million costs still remain in the IT conversion in 2012. In addition, risk products are degraded by...
Aug. 30, 2012 | Allgemein, company news @en, DE
Hospira has announced the acquisition of the manufacturing plant for medicinal products (ie for penicillins) and research and development unit (R & D) of Indian pharmaceutical company Orchid Chemicals & Pharmaceuticals Ltd., for $200 million. The production...
Aug. 30, 2012 | Allgemein, company news @en, DE, new products
For patients suffering from COPD (a combination of various lung diseases), the prospect of a more effective and non-injurious drug from the pharmaceutical company Novartis has been created. They indicated that the lung drug QVA149 had proven itself in the latest...
